FDA Alert: Medication and Medical Device Approvals
September 12, 2016
The US FDA has approved the marketing of computerized cognitive tes...
Read More
Most Children With TBI Present to Primary Care, Not Emergency Department
June 23, 2016
A four-year study recently published by researchers from the Childr...
Read More
FDA Alerts: Pimavanserin, Vortioxetine, Aripiprazole, and Olanzapine
May 18, 2016
Recent updates from the FDA include the approval of pimavanserin to...
Read More
American Psychiatric Association Practice Guideline for Use of Antipsychotics in Patients With Dementia
May 13, 2016
At the December 2015 meeting, the American Psychiatric Association ...
Read More
FDA Alerts: Pimavanserin, Diabetes Medications, and Opioids
April 18, 2016
The US FDA warned of heart risk failure with diabetes medications a...
Read More
Mortality Risk Associated with Antipsychotics in Parkinson's Disease
April 6, 2016
In a retrospective matched-cohort study, Weintraub et al. examined ...
Read More
![]()
March News and New Research
March 1, 2016
New CDC Guidelines for Opioid Use, A Novel Risk Assessment Tool fo...
Read More
![]()
February News and New Research
February 1, 2016
ABPN updates MOC Part IV requirements yet again, RAISE data show c...
Read More
![]()
January News and New Research
January 1, 2016
Death and serious brain injury in Phase I trial for an agent actin...
Read More
![]()
July News and New Research
July 1, 2015
US FDA approves brexpiprazole, antidepressant/NSAID combination an...
Read More
![]()
June News and New Research
June 1, 2015
LAI risperidone superior to oral risperidone in first-episode psyc...
Read More